These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3569605)

  • 61. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects.
    Ueda Y; Honda M; Hatano M
    Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency.
    McCaa RE
    Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of chronic guanfacine administration on high plasma vasopressin levels in essential hypertension.
    Berkman K; Tözün N; Taga Y; Dedeoğlu A; Onat F; Bekiroğlu N
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):67-71. PubMed ID: 2407671
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL; Zeng ZP; Tong AL; Lu L; Chen S; Li M; Fu CL; Wang YH; Sun ML
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of acute and chronic vitamin D administration on systemic renin angiotensin system in essential hypertensives and controls.
    Bernini G; Carrara D; Bacca A; Carli V; Virdis A; Rugani I; Duranti E; Ghiadoni L; Bernini M; Taddei S
    J Endocrinol Invest; 2013 Apr; 36(4):216-20. PubMed ID: 23645099
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects.
    Ichihara A; Suzuki H; Saruta T
    J Lab Clin Med; 1993 Oct; 122(4):432-40. PubMed ID: 8228558
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
    Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of the effects of diuretic therapy and low sodium intake in isolated systolic hypertension.
    Niarchos AP; Weinstein DL; Laragh JH
    Am J Med; 1984 Dec; 77(6):1061-8. PubMed ID: 6391163
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of somatostatin on plasma renin activity and blood pressure in patients with essential hypertension.
    Izumi Y; Honda M; Tsuchiya M; Ueda Y; Hatano M
    Endocrinol Jpn; 1980 Aug; 27(4):505-11. PubMed ID: 6109626
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sodium excretion and renin secretion after continuous versus pulsatile infusion of oxytocin in rats.
    Sjöquist M; Huang W; Jacobsson E; Skøtt O; Stricker EM; Sved AF
    Endocrinology; 1999 Jun; 140(6):2814-8. PubMed ID: 10342872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical evaluation of the captopril screening test for primary aldosteronism.
    Naomi S; Iwaoka T; Umeda T; Inoue J; Hamasaki S; Miura F; Fujii Y; Sato T
    Jpn Heart J; 1985 Jul; 26(4):549-56. PubMed ID: 3903249
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity.
    Collins RD; Weinberger MH; Dowdy AJ; Nokes GW; Gonzales CM; Luetscher JA
    J Clin Invest; 1970 Jul; 49(7):1415-26. PubMed ID: 4317384
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Aldosterone in primary hypertension relationship to plasma renin activity and urinary electrolytes and a comparison with normotensive subjects.
    Tolagen K
    Scand J Clin Lab Invest; 1978 Sep; 38(5):487-93. PubMed ID: 705230
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Possible pathogenetic role of 11 beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) gene polymorphisms in arterial hypertension].
    Morales MA; Carvajal CA; Ortiz E; Mosso LM; Artigas RA; Owen GI; Fardella CE
    Rev Med Chil; 2008 Jun; 136(6):701-10. PubMed ID: 18769825
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of sodium and potassium loading on urinary kallikrein-like activity in young patients with borderline hypertension.
    Ando K; Ito Y; Noda H; Fujita T
    Jpn Circ J; 1985 Nov; 49(11):1151-8. PubMed ID: 3854057
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Significance of urinary angiotensinogen in essential hypertension as a function of plasma renin and aldosterone status.
    Lantelme P; Rohrwasser A; Vincent M; Cheng T; Gardier S; Legedz L; Bricca G; Lalouel JM; Milon H
    J Hypertens; 2005 Apr; 23(4):785-92. PubMed ID: 15775783
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Renal prostaglandin E2 and the renin-angiotensin system in hypertensive disorders in man.
    Kuylenstierna J; Karlberg BE; Morales O
    Prostaglandins Leukot Med; 1985 Apr; 18(1):19-30. PubMed ID: 3889934
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin-angiotensin system.
    Ho KY; Weissberger AJ
    Metabolism; 1990 Feb; 39(2):133-7. PubMed ID: 2405233
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of chronic infusion of renin inhibitor A-64662 in sodium-depleted monkeys.
    Verburg KM; Kleinert HD; Kadam JR; Chekal MA; Mento PF; Wilkes BM
    Hypertension; 1989 Mar; 13(3):262-72. PubMed ID: 2646217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.